In recent times, osteoporosis, once a silent epidemic, has emerged as a serious health risk. Osteoporosis is linked to high rates of death, morbidity and expensive medical costs worldwide because it makes bones more brittle and increases the risk of fractures. Despite being a significant risk factor for osteoporosis in postmenopausal women due to ovarian hormone deficiency, hormone replacement therapy (HRT), which is arguably the most successful therapy, is not recommended because it raises the risk of cardiovascular and breast cancer. Certain side effects are connected to the other therapeutic agents currently on the market. It is thought that phytoestrogens contribute to preserving or enhancing skeletal health in this particular context. The current study examines scientific data on therapeutic plants whose antiosteoporosis properties have already been established. How these plants work may vary; in certain situations, they act by strengthening defences against oxidative stress, or they bind with estrogen receptors that show answers at both the molecular and cell levels. This review covers eighteen plants and provides a brief synopsis of each plant's morphology, phytoconstituents, family, common name and potential mechanism of action.
Loading....